Coronavirus: South Africa halts AstraZeneca vaccine drive
- South Africa data showed AstraZeneca shot had limited efficacy against country’s dominant virus variant
- A World Health Organization panel will meet in Geneva to examine the shot
.png?itok=arIb17P0)
South Africa suspended the start of its AstraZeneca inoculation programme over concerns the shot does not work on a new variant, with WHO experts due to meet to discuss the vaccine already facing questions about its efficacy for over-65s.
A trial showed the vaccine provides only “minimal” protection against mild to moderate Covid-19 caused by the variant first detected in South Africa, a setback to the global fight against the pandemic as many poorer nations are relying on the logistical advantages offered by the AstraZeneca shot.
Africa’s hardest-hit nation was due to start its campaign in the coming days with a million AstraZeneca doses but the government decided to hold off in light of the results from the trial conducted by the University of Witatersrand in Johannesburg.
“It’s a temporary issue that we have to hold on AstraZeneca until we figure out these issues,” Health Minister Zweli Mkhize said on Sunday.
Instead, it will offer vaccines developed by Johnson & Johnson and Pfizer in the coming weeks.
The 1.5 million AstraZeneca vaccines obtained by South Africa, which will expire in April, will be kept until scientists give clear indications on their use, he added.
AstraZeneca, which developed the shot with the University of Oxford, said: “We do believe our vaccine will still protect against severe disease”.
09:50
SCMP Explains: What's the difference between the major Covid-19 vaccines?
A company spokesperson said researchers were already working to update the vaccine to deal with the South African variant, which has been spreading rapidly around the world.
A World Health Organization panel was due to meet on Monday in Geneva to examine the shot, which is a major component of the initial Covax global vaccine rollout that covers some 145 countries - mostly lower and lower-middle income economies.
Out of the initial 337.2 million Covax doses, 240 million are AstraZeneca shots, which do not require the supercold storage needed for the Pfizer and Moderna vaccines.
Unwilling to wait for UN programme, poorer countries seek their own vaccines
However France will use it beginning Saturday, with a priority for health care workers, after its first batch arrived Friday evening. Germany, Ireland, Spain and Austria will also start offering the shot, while Portugal will receive deliveries early next week.
The coronavirus pandemic has claimed more than 2.3 million lives globally out of nearly 106 million known infections, and despite the AstraZeneca setback, vaccine rollouts in other countries are gathering pace.
Hungarian authorities said on Sunday they have approved Russia’s Sputnik V shot, while Cambodia became the latest nation to receive delivery of the Chinese Sinopharm vaccine, taking on 600,000 doses of the jab.
Efforts were under way in the United States, the hardest-hit nation, to accelerate its mass vaccination programme, which has been plagued by supply and logistics issues.
President Joe Biden, who took office last month, said his predecessor Donald Trump’s handling of the pandemic “was even more dire than we thought”.
When will air travel resume? Recovery this year looks bleak
“We thought they had indicated there was a lot more vaccine available, and it didn’t turn out to be the case,” he told CBS News on Sunday. “So that’s why we’ve ramped up every way we can.”
Biden also asked American football fans to “be careful”, with health experts worried about the virus spreading at parties expected during and after the Super Bowl, the country’s biggest sporting event.
There was some good news out of Israel, which began emerging out of its third lockdown on Sunday. Israel’s vaccination programme is considered the fastest per-capita in the world.
In neighbouring Jordan, hundreds of thousands of students returned to classrooms on Sunday after almost a year.
Schools were also expected to reopen on Monday in Romania, the Netherlands, Denmark and Austria. Museums and shops were also due to reopen in Austria.
WHO chief urges ‘massive scale-up’ in vaccine production
And there was both gloom and optimism in Venice, where the annual Carnival kicked off with much smaller celebrations.
“Venice is strange this year. It is shocking to see it so empty,” said Armando Bala, a costume salesman.
“We are here today to say that Venice can live and be reborn, as it has several times in its history.”
Additional reporting by Reuters and Bloomberg
